Brucellosis Vaccines Market to Develop Rapidly by 2025

Posted by Sachin Darakhe on September 26th, 2019

Brucellosis is an extremely transmissible zoonotic infection. Bacterial genus Brucella is responsible for the infection. Brucellaare transferred from animals to humans through consumption of infected foodstuff, undercooked meat, or unpasteurized milk from diseased animals; direct contact with an infected animal or their discharges; or inhalation of aerosols.

View Report –

https://www.transparencymarketresearch.com/brucellosis-vaccines-market.html

According to the WHO, zoonotic diseases and infections are naturally transferred between vertebrate animals and humans. A zoonotic agent may be a fungus, virus, bacterium, or any other infectious disease agent. Brucellosis is an old disease that has been known by several names such as undulant fever, gastric remittent fever, Malta fever, and Mediterranean fever. Humans are unintended hosts, but brucellosis continues to be a highly significant community health concern at the global level and the most common zoonotic infection as well.

Request Brochure of Brucellosis Vaccines Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34439

Brucella bacteria are minor aerobic intracellular coccobacilli, which are localized in reproductive organs of the host animal, causing infertility and abortions. They are sheltered in large numbers in the animal’s placental fluid, milk, urine, and other fluids. To date, eight species of Brucella bacteria have been identified, termed primarily after the source animal or symptoms of infection. Out of these, four species possess medium to serious human pathogenicity. These are Brucella canis(transferred from dogs; moderate pathogenicity), Brucella abortus (transferred from cattle; moderate pathogenicity), Brucella suis (transferred from pigs; high pathogenicity), and Brucella melitensis (transferred from sheep; maximum pathogenicity).

The global brucellosis vaccines market can be segmented based on type of product, application, end-user, and geography. Based on type of product, the brucellosis vaccines market has been classified as DNA vaccines, subunit vaccines, vector vaccines, B. Abortus recombinant mutants, and others. Based on application, the market has been categorized into cattle, sheep, pigs, and others. Based on end-user, the market has been classified into veterinary hospitals, veterinary clinics, and animal care centers. Based on geography, the global brucellosis vaccines market has been divided into North America, Europe, Asia Pacific, and Rest of World.

Major players operating in the global brucellosis vaccines market are Merck Animal Health, Boehringer Ingelheim Vetmedica, Ceva, Bayer AG, Biogenesis-Bago, Heska Corporation, Indian Immunologicals Ltd., Lohmann Animal Health, and Merial Ltd.

Like it? Share it!


Sachin Darakhe

About the Author

Sachin Darakhe
Joined: August 12th, 2019
Articles Posted: 296

More by this author